Literature DB >> 11829199

Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia.

K Raaska1, V Raitasuo, P J Neuvonen.   

Abstract

OBJECTIVE: To study the effect of influenza vaccine on serum clozapine, N-desmethylclozapine and clozapine-N-oxide steady-state concentrations in patients with schizophrenia.
METHODS: This was an open-label study in 14 schizophrenic inpatients (with 2 drop-outs) using clozapine. Serum trough concentrations of clozapine. N-desmethylclozapine and clozapine-N-oxide, as well as the concentration of c-reactive protein (CRP), were measured immediately before conventional trivalent influenza vaccination and 2, 4, 7 and 14 days after the vaccination.
RESULTS: Influenza vaccination had no significant effect on serum concentrations of clozapine, N-desmethylclozapine or clozapine-N-oxide. No changes in the clinical effects of clozapine were observed after vaccination. Influenza vaccination did not increase CRP. However, two drop-out patients who developed upper respiratory and abdominal symptoms had increased and elevated serum concentrations of clozapine, compared with the baseline.
CONCLUSIONS: Influenza vaccination using conventional trivalent influenza vaccine does not affect serum concentrations of clozapine or its main metabolites. However, an infection-related increase in CRP may be associated with increased serum concentration of clozapine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11829199     DOI: 10.1007/s002280100375

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

Review 1.  Vaccine-Drug Interactions: Cytokines, Cytochromes, and Molecular Mechanisms.

Authors:  Paolo Pellegrino; Cristiana Perrotta; Emilio Clementi; Sonia Radice
Journal:  Drug Saf       Date:  2015-09       Impact factor: 5.606

2.  Infections, vaccinations, drugs and interactions.

Authors:  Paolo Pellegrino; Emilio Clementi; Sonia Radice
Journal:  Eur J Clin Pharmacol       Date:  2014-05-02       Impact factor: 2.953

3.  Infections and possible vaccine-drug interactions.

Authors:  Kari Raaska; Pertti J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  2014-05-08       Impact factor: 2.953

4.  Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna).

Authors:  Christian Knöchel; Gudrun Hefner; Thomas Stiehl; Walter Schmidbauer
Journal:  J Clin Psychopharmacol       Date:  2022-01-28       Impact factor: 3.118

Review 5.  COVID-19 vaccination for people with severe mental illness: why, what, and how?

Authors:  Victor Mazereel; Kristof Van Assche; Johan Detraux; Marc De Hert
Journal:  Lancet Psychiatry       Date:  2021-02-03       Impact factor: 27.083

6.  Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination.

Authors:  Deborah Thompson; Clay M Delorme; Randall F White; William G Honer
Journal:  J Psychiatry Neurosci       Date:  2021-03-05       Impact factor: 6.186

Review 7.  Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment.

Authors:  Françoise Stanke-Labesque; Elodie Gautier-Veyret; Stephanie Chhun; Romain Guilhaumou
Journal:  Pharmacol Ther       Date:  2020-07-11       Impact factor: 12.310

Review 8.  Current trends in drug metabolism and pharmacokinetics.

Authors:  Yuhua Li; Qiang Meng; Mengbi Yang; Dongyang Liu; Xiangyu Hou; Lan Tang; Xin Wang; Yuanfeng Lyu; Xiaoyan Chen; Kexin Liu; Ai-Ming Yu; Zhong Zuo; Huichang Bi
Journal:  Acta Pharm Sin B       Date:  2019-10-18       Impact factor: 11.413

9.  Clozapine and COVID-19 Vaccination: Effects on blood levels and leukocytes. An observational cohort study.

Authors:  Selene R T Veerman; Timo Moscou; Jan P A M Bogers; Dan Cohen; Peter F J Schulte
Journal:  Acta Psychiatr Scand       Date:  2022-04-01       Impact factor: 7.734

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.